跳至主要内容
临床试验/NCT01394445
NCT01394445已完成3 期

Influence of Physostigmine on Patient-Controlled Analgesia

Medical University of Graz1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2011年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
opioid consumption

研究概览

简要总结

The investigators hypothesize that the administration of physostigmine in the postoperative period after nephrectomy reduces opioid consumption.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 18 years old
  • At least 50 kg
  • Suitable for PCA

排除标准

  • Bronchial asthma/severe or exacerbated COPD
  • Stenoses/spasms of intestine, urinary tract, biliary tract
  • Closed traumatic brain injury
  • Severely reduced left ventricular function (EF<30%)
  • Recent myocardial infarction
  • Recent stroke
  • Known allergy or hypersensitivity or contraindications against hydromorphone, physostigmine
  • History of alcohol or drug abuse
  • Patients enrolled in another study
  • Women of childbearing age without a negative pregnancy test

研究组 & 干预措施

Physostigmine

Active Comparator

干预措施: Physostigmine (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

opioid consumption

时间窗: 24 hours

次要结局

  • pain scores(24 hours)

研究者

发起方
Medical University of Graz
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Pilot Study of Physostigmine-Enhanced Opioid... | 临床试验